Cost effectiveness of pre-referral antimalarial treatment in severe malaria among children in sub-Saharan Africa.

ABSTRACT:

Background

In 2013, 78% of malaria deaths occurred in children aged 5 years and below, in sub-Saharan Africa. Treatment of severe malaria requires a health facility with inpatient care. However, in most sub-Sahara African countries, access to health facilities is a major problem. Pre-referral antimalarial treatments aim to delay the progress of severe malaria as patients seek to access health facilities. Rectal artesunate can be administered in the community as a pre-referral treatment in rural hard-to-reach areas. In Kenya, though pre-referral rectal artesunate has been included in the National Guidelines for pre-referral treatment, it is yet to be implemented in the public healthcare system. It is important, therefore, to establish its cost-utility compared to current parenteral

SUBMITTER: Rakuomi V 

PROVIDER: S-EPMC5512821 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature